LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 33

Search options

  1. Article: Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients.

    Vermassen, Tijl / Geboes, Karen / Lumen, Nicolaas / Van Praet, Charles / Rottey, Sylvie / Delanghe, Joris

    Clinical kidney journal

    2024  Volume 17, Issue 1, Page(s) sfae006

    Abstract: Background: Tyrosine kinase inhibitors (TKIs) are associated with kidney function deterioration. A shift is ongoing towards glomerular filtration rate (GFR) equations based on other protein markers, such as cystatin C (CSTC) and β-trace protein (BTP). ... ...

    Abstract Background: Tyrosine kinase inhibitors (TKIs) are associated with kidney function deterioration. A shift is ongoing towards glomerular filtration rate (GFR) equations based on other protein markers, such as cystatin C (CSTC) and β-trace protein (BTP). We evaluated various GFR equations for monitoring of kidney function in actively treated oncology patients.
    Methods: We monitored 110 patients receiving a TKI. Blood and urine were collected during therapy. Serum analysis included creatinine (Cr), CSTC and BTP; for consequent GFR determination. Urine was analysed for protein, albumin, immunoglobulin G, and α-1-microglobulin. A similar analysis was done in a patient subgroup receiving immune checkpoint inhibitors (ICI) as prior or subsequent line of therapy.
    Results: Cr remained constant during TKI treatment (
    Conclusion: GFR equations, in which CSTC is incorporated, fail to correctly estimate the GFR in oncology patients treated with TKIs. As TKI-treated patients show clear signs of glomerular injury, further assessment is needed on how to correctly monitor the kidney function in actively treated oncology patients.
    Language English
    Publishing date 2024-01-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 2655800-2
    ISSN 2048-8513 ; 2048-8505
    ISSN (online) 2048-8513
    ISSN 2048-8505
    DOI 10.1093/ckj/sfae006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now?

    Cleymaet, Robbert / Vermassen, Tijl / Coopman, Renaat / Vermeersch, Hubert / De Keukeleire, Stijn / Rottey, Sylvie

    International journal of molecular sciences

    2022  Volume 23, Issue 23

    Abstract: Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors. If feasible, surgery is the preferred treatment modality. Nevertheless, some malignancies have a tendency of recurrence, with possible distant ... ...

    Abstract Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors. If feasible, surgery is the preferred treatment modality. Nevertheless, some malignancies have a tendency of recurrence, with possible distant metastasis. Alternative treatment strategies, such as primary radiation or chemotherapeutics, often present low response rates. As a result, there is an unmet need for novel therapeutic approaches. Nowadays, target-based therapies (e.g., small inhibitors and immunotherapy) are used by the medical oncologist for possible treatment of advanced SGMs. Based on recent published trials, some novel treatments may provide additional disease control for some patients. However, sample sizes are small, the general findings are unsatisfactory, and a lot of uncertainties remain to be elucidated. Nevertheless, research shows that patients do not benefit from blind administration of systemic treatments and therefore a more personalized approach is highly needed. The aim of this review paper is to summarize the most recent advances in the biological understanding and molecular pathways of salivary gland cancers, the association of these pathways with the current treatments used and their implications for more personalized targeted-based therapies.
    Language English
    Publishing date 2022-11-28
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms232314891
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study.

    Vermassen, Tijl / De Keukeleire, Stijn / Saerens, Michael / Heerwegh, Sylvester / Debacker, Jens M / Huvenne, Wouter / Deron, Philippe / Creytens, David / Ferdinande, Liesbeth / Rottey, Sylvie / Bachert, Claus / Duprez, Fréderic / Van Zele, Thibaut

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

    2024  

    Abstract: Purpose: Intestinal-type adenocarcinoma (ITAC) is a rare sinonasal malignancy. Curative treatment requires multidisciplinary approach, with surgical options consist of the endonasal endoscopic approach (EEA) and external surgery (EXTS). Here, we provide ...

    Abstract Purpose: Intestinal-type adenocarcinoma (ITAC) is a rare sinonasal malignancy. Curative treatment requires multidisciplinary approach, with surgical options consist of the endonasal endoscopic approach (EEA) and external surgery (EXTS). Here, we provide the post-operative and survival results from a single-center long-term follow-up.
    Methods: We report long-term follow-up of 92 ITAC cases treated between 1998 and 2018, treated with EEA (n = 40) or EXTS (n = 52). Survival estimates, post-operative complications and duration of hospitalization were compared between surgical modalities.
    Results: Baseline characteristics were similar. A higher number of T4b tumors (16%), and subsequently more tumoral invasion (39%), was present in patients undergoing EXTS compared to EEA (3% and 18%, respectively). No difference in Barnes histology subtypes was noticed. Patients undergoing EEA had a shorter post-operative hospitalization stay versus EXTS (4 versus 7 days). Use of EEA was associated to improved disease-specific survival (DSS; 11.4 versus 4.4 years; HR
    Conclusions: Long-term follow-up in locally advanced ITAC demonstrates that resection by EEA is correlated with improved DSS compared to EXTS, especially for T3-4 tumors. No significant differences between both treatment modalities was observed regarding per- and post-operative complications, although hospitalization in patients undergoing EEA was shorter than for patients treated with EXTS. These results confirm that EEA should remain the preferred surgical procedure in operable cases of sinonasal ITAC.
    Language English
    Publishing date 2024-01-16
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1017359-6
    ISSN 1434-4726 ; 0937-4477
    ISSN (online) 1434-4726
    ISSN 0937-4477
    DOI 10.1007/s00405-024-08447-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Tissue

    Vermassen, Tijl / Van Den Broeck, Arne / Lumen, Nicolaas / Callewaert, Nico / Rottey, Sylvie / Delanghe, Joris

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

    2021  Volume 26, Issue 3, Page(s) 275–285

    Abstract: Purpose: Only few biomarkers have been evaluated for their prognostic value following radical prostatectomy. We explored if tissue : Materials and methods: Tissue : Results: Majority presented with Gleason score 3 + 4 (41%), extensive local ... ...

    Abstract Purpose: Only few biomarkers have been evaluated for their prognostic value following radical prostatectomy. We explored if tissue
    Materials and methods: Tissue
    Results: Majority presented with Gleason score 3 + 4 (41%), extensive local disease (62%) and without pelvic lymph nodes invasion (83%). Several parameters (low T stage, low Gleason score, low EAU risk groups for BCR, absence of positive surgical margins, high ratio of fucosylated triantennary structures on total of multiantennary structures [3AFc/MA], low ratio of fucosylated biantennary with core-branched
    Conclusions: Tissue
    MeSH term(s) Aged ; Biomarkers, Tumor/metabolism ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Glycomics ; Glycosylation ; Humans ; Lymph Node Excision ; Male ; Margins of Excision ; Middle Aged ; Polysaccharides/metabolism ; Predictive Value of Tests ; Prostatectomy ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Radiotherapy, Adjuvant ; Risk Assessment ; Risk Factors ; Time Factors
    Chemical Substances Biomarkers, Tumor ; Polysaccharides
    Language English
    Publishing date 2021-03-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 1324372-x
    ISSN 1366-5804 ; 1354-750X
    ISSN (online) 1366-5804
    ISSN 1354-750X
    DOI 10.1080/1354750X.2021.1891290
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?

    Almangush, Alhadi / De Keukeleire, Stijn / Rottey, Sylvie / Ferdinande, Liesbeth / Vermassen, Tijl / Leivo, Ilmo / Mäkitie, Antti A

    Cancers

    2022  Volume 14, Issue 6

    Abstract: The evaluation of tumor-infiltrating lymphocytes (TILs) has received global attention as a promising prognostic cancer biomarker that can aid in clinical decision making. Proof of their significance was first shown in breast cancer, where TILs are now ... ...

    Abstract The evaluation of tumor-infiltrating lymphocytes (TILs) has received global attention as a promising prognostic cancer biomarker that can aid in clinical decision making. Proof of their significance was first shown in breast cancer, where TILs are now recommended in the classification of breast tumors. Emerging evidence indicates that the significance of TILs extends to other cancer types, including head and neck cancer. In the era of immunotherapy as a treatment choice for head and neck cancer, assessment of TILs and immune checkpoints is of high clinical relevance. The availability of the standardized method from the International Immuno-oncology Biomarker Working Group (IIBWG) is an important cornerstone toward standardized assessment. The aim of the current article is to summarize the accumulated evidence and to establish a clear premise for future research toward the implementation of TILs in the personalized management of head and neck squamous cell carcinoma patients.
    Language English
    Publishing date 2022-03-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers14061558
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives.

    De Keukeleire, Stijn J / Vermassen, Tijl / Hilgert, Elien / Creytens, David / Ferdinande, Liesbeth / Rottey, Sylvie

    Cancers

    2021  Volume 13, Issue 7

    Abstract: The era of immune checkpoint inhibitors has altered the therapeutic landscape in squamous cell cancer of the head and neck (SCCHN). Our knowledge about the tumor microenvironment has fueled the research in SCCHN, leading to several well-known and less- ... ...

    Abstract The era of immune checkpoint inhibitors has altered the therapeutic landscape in squamous cell cancer of the head and neck (SCCHN). Our knowledge about the tumor microenvironment has fueled the research in SCCHN, leading to several well-known and less-known prognostic and predictive biomarkers. The clinical staging, p16/HPV status, and PD-L1 expression are currently the main tools for assessing the patients' diagnosis and prognosis. However, several novel biomarkers have been thoroughly investigated, some reaching actual significant clinical contributions. The untangling of the immune infiltrate with the subtyping of tissue-associated tumor infiltrating lymphocytes, tumor-associated macrophages, and circulating blood-based biomarkers are an interesting avenue to be further explored and prospectively assessed. Although PD-L1 expression remains the most important response predictor for immune checkpoint inhibitors, several flaws impede proper assessment such as technical issues, different scoring protocol, and intra-, inter-, and temporal heterogeneity. In addition, the construction of an immune-related gene panel has been proposed as a prognostic and predictive stratification but lacks consensus. Recently, the role of microbioma have also been explored regarding its systemic and antitumor immunity. This review gives a comprehensive overview of the aforementioned topics in SCCHN. To this end, the integration of these clinically advantageous biomarkers via construction of an immunogram or nomogram could be an invaluable tool for SCCHN in future prospects.
    Language English
    Publishing date 2021-04-04
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers13071714
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Exercise Induced Myoglobinuria is Determined by Haptoglobin Polymorphism.

    Maenhout, Thomas M / Vermassen, Tijl / Dalewyn, Lode / Buyzere, Marc L De / Delanghe, Joris R

    Clinical laboratory

    2021  Volume 67, Issue 5

    Abstract: Background: In professional soccer players (n = 27), confounders of quantitative myoglobinuria following physical training were assessed in order to improve interpretation of post-exercise myoglobinuria.: Methods: Urine samples were collected in the ... ...

    Abstract Background: In professional soccer players (n = 27), confounders of quantitative myoglobinuria following physical training were assessed in order to improve interpretation of post-exercise myoglobinuria.
    Methods: Urine samples were collected in the morning before training sessions, 48 to 72 hours following a game. Urine myoglobin was assayed using immunoturbidimetry. Blood was drawn 48 hours following training session. Creatinine was assayed using a Jaffe method. Creatine kinase (CK) activity was assayed according to the IFCC reference method. Serum myoglobin was assayed using the same assay as the one used for urine. Hp polymorphism was assessed on hemoglobin supplemented serum. Serum Hp concentration was assayed nephelometrically. Training intensity was assessed using a wearable GPS tracking system. Physical load monitoring included the covered total distance, the distance at different speed zones, and the number of sprints/accelerations/decelerations/jumps. Multiple regression analysis was used to detect the determinants of post-exercise myoglobinuria.
    Results: Myoglobinuria negatively correlated with serum haptoglobin (Hp) concentration. Athletes presented with Hp values, which were lower than the Hp phenotype reference ranges, which can be explained by depletion of circulating Hp stores. Myoglobinuria was most pronounced in players carrying a Hp 2-2 phenotype, which is associated with the lowest Hp reference range. Myoglobin clearance was inversely correlated with Hp 2-2 concentration. Correlation between myoglobinuria and biomarkers of muscle damage was weak. Neither age nor glomerular filtration rate were found to be confounders of myoglobinuria. When comparing myoglobinuria with training intensity, the number of sprints, average acceleration speed, and maximal speed were determining factors for predicting exercise-induced myoglobinuria.
    Conclusions: In athletes, plasma myoglobin binding capacity is depleted. Moderate myoglobinuria not only should be regarded as a muscle damage marker, but also should be interpreted as an indicator for Hp depletion. Apart from its significance as a biomarker for muscle damage and rhabdomyolysis, myoglobinuria in athletes should be a warning that the heme binding capacity of plasma Hp is depleted, indicating an exhausted defense against Fenton chemistry induced free radicals. Fenton chemistry is associated with free radical formation, which is to be avoided because of the causative relationship with inflammatory processes and tissue damage.
    MeSH term(s) Creatinine ; Exercise ; Haptoglobins/genetics ; Humans ; Myoglobin/genetics ; Myoglobinuria/diagnosis ; Myoglobinuria/genetics ; Rhabdomyolysis
    Chemical Substances Haptoglobins ; Myoglobin ; Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2021-05-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1307629-2
    ISSN 1433-6510 ; 0941-2131
    ISSN 1433-6510 ; 0941-2131
    DOI 10.7754/Clin.Lab.2020.200855
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Prostate Protein N-Glycosylation Profiling by Means of DNA Sequencer-Assisted Fluorophore-Assisted Carbohydrate Electrophoresis.

    Vermassen, Tijl / Callewaert, Nico / Rottey, Sylvie / Delanghe, Joris R

    Methods in molecular biology (Clifton, N.J.)

    2019  Volume 1972, Page(s) 235–250

    Abstract: DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis allows for accurate profiling of the asparagine-linked (N-) glycosylation patterns, a posttranslational modification present on many soluble and membrane proteins. This technique ... ...

    Abstract DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis allows for accurate profiling of the asparagine-linked (N-) glycosylation patterns, a posttranslational modification present on many soluble and membrane proteins. This technique has been extensively tested to identify N-glycosylation patterns associated with serum proteins. Here we describe the use of DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis to identify the N-glycosylation patterns of prostate proteins in urine.
    MeSH term(s) Carbohydrates/analysis ; Carbohydrates/chemistry ; Electrophoresis/methods ; Fluorescent Dyes/chemistry ; Glycomics/methods ; Glycoproteins/chemistry ; Glycosylation ; Humans ; Male ; Polysaccharides/analysis ; Prostate/metabolism ; Proteins/analysis ; Proteins/genetics ; Sequence Analysis, DNA/instrumentation
    Chemical Substances Carbohydrates ; Fluorescent Dyes ; Glycoproteins ; Polysaccharides ; Proteins
    Language English
    Publishing date 2019-03-04
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-4939-9213-3_17
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: To treat or not to treat? Managing comorbidities in cancer patients under immune checkpoint inhibition.

    De Keukeleire, Stijn / Vermassen, Tijl / De Schoenmakere, Gert / Kruse, Vibeke / Vermaelen, Karim / Rottey, Sylvie

    Acta clinica Belgica

    2019  Volume 75, Issue 6, Page(s) 434–441

    Abstract: ... ...

    Abstract Objectives
    MeSH term(s) Age Factors ; Autoimmune Diseases/epidemiology ; Brain Neoplasms/secondary ; Comorbidity ; Functional Status ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunocompromised Host ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/therapy ; Liver Diseases/epidemiology ; Neoplasms/drug therapy ; Neoplasms/epidemiology ; Organ Transplantation ; Renal Dialysis ; Renal Insufficiency/epidemiology ; Ventricular Dysfunction, Left/epidemiology
    Chemical Substances Immune Checkpoint Inhibitors
    Language English
    Publishing date 2019-07-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 390201-8
    ISSN 2295-3337 ; 0001-5512 ; 1784-3286
    ISSN (online) 2295-3337
    ISSN 0001-5512 ; 1784-3286
    DOI 10.1080/17843286.2019.1646516
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?

    De Keukeleire, Stijn J / Vermassen, Tijl / Nezhad, Zahra M / Kerre, Tessa / Kruse, Vibeke / Vlierberghe, Hans Van / Vermaelen, Karim / Rottey, Sylvie

    Immunotherapy

    2021  Volume 13, Issue 5, Page(s) 409–418

    Abstract: More patients with chronic hepatitis B and C infection are being exposed to immune checkpoint inhibitors (ICIs), but the safety and efficacy of ICIs in patients with chronic viral hepatitis are still poorly described. To explore this interaction, we ... ...

    Abstract More patients with chronic hepatitis B and C infection are being exposed to immune checkpoint inhibitors (ICIs), but the safety and efficacy of ICIs in patients with chronic viral hepatitis are still poorly described. To explore this interaction, we identified eight studies of cancer patients with viral hepatitis treated with one or more ICIs, formally assessed tumor responses and safety by grading liver dysfunction. ICIs appear to be relatively safe in HBV/HCV-infected patients, and hepatitis related to viral reactivation is rare. In some patients, viral load regressed during ICI treatment, so immune checkpoints may play a role in viral clearance. HBV/HCV do not appear to be a contraindication to ICIs, although careful clinical and biochemical follow-up is recommended and, whenever necessary, antiviral therapy commenced.
    MeSH term(s) Chronic Disease ; Hepacivirus/drug effects ; Hepacivirus/physiology ; Hepatitis B virus/drug effects ; Hepatitis B virus/physiology ; Hepatitis, Viral, Human/complications ; Hepatitis, Viral, Human/drug therapy ; Hepatitis, Viral, Human/immunology ; Hepatitis, Viral, Human/virology ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Liver/drug effects ; Liver/immunology ; Neoplasms/complications ; Neoplasms/drug therapy ; Neoplasms/immunology ; Neoplasms/virology ; Review Literature as Topic ; Viral Load/drug effects ; Virus Activation/drug effects
    Chemical Substances Immune Checkpoint Inhibitors
    Language English
    Publishing date 2021-01-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 2495964-9
    ISSN 1750-7448 ; 1750-743X
    ISSN (online) 1750-7448
    ISSN 1750-743X
    DOI 10.2217/imt-2020-0273
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top